Literature DB >> 31327392

Preventing dementia by preventing stroke: The Berlin Manifesto.

Vladimir Hachinski1, Karl Einhäupl2, Detlev Ganten3, Suvarna Alladi4, Carol Brayne5, Blossom C M Stephan6, Melanie D Sweeney7, Berislav Zlokovic7, Yasser Iturria-Medina8, Costantino Iadecola9, Nozomi Nishimura10, Chris B Schaffer10, Shawn N Whitehead11, Sandra E Black12, Leif Østergaard13, Joanna Wardlaw14, Steven Greenberg15, Leif Friberg16, Bo Norrving17, Brian Rowe18, Yves Joanette19, Werner Hacke20, Lewis Kuller21, Martin Dichgans22, Matthias Endres23, Zaven S Khachaturian24.   

Abstract

The incidence of stroke and dementia are diverging across the world, rising for those in low- and middle-income countries and falling in those in high-income countries. This suggests that whatever factors cause these trends are potentially modifiable. At the population level, neurological disorders as a group account for the largest proportion of disability-adjusted life years globally (10%). Among neurological disorders, stroke (42%) and dementia (10%) dominate. Stroke and dementia confer risks for each other and share some of the same, largely modifiable, risk and protective factors. In principle, 90% of strokes and 35% of dementias have been estimated to be preventable. Because a stroke doubles the chance of developing dementia and stroke is more common than dementia, more than a third of dementias could be prevented by preventing stroke. Developments at the pathological, pathophysiological, and clinical level also point to new directions. Growing understanding of brain pathophysiology has unveiled the reciprocal interaction of cerebrovascular disease and neurodegeneration identifying new therapeutic targets to include protection of the endothelium, the blood-brain barrier, and other components of the neurovascular unit. In addition, targeting amyloid angiopathy aspects of inflammation and genetic manipulation hold new testable promise. In the meantime, accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles (e.g., reduced prevalence of smoking) and vascular disease, including stroke, have better cognitive function and lower dementia rates. At the individual levels, trials have demonstrated that anticoagulation of atrial fibrillation can reduce the risk of dementia by 48% and that systolic blood pressure lower than 140 mmHg may be better for the brain. Based on these considerations, the World Stroke Organization has issued a proclamation, endorsed by all the major international organizations focused on global brain and cardiovascular health, calling for the joint prevention of stroke and dementia. This article summarizes the evidence for translation into action.
Copyright © 2019 the Alzheimer's Association and the World Stroke Organisation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognitive impairment; Dementia; Neurovascular unit; Policy; Prevention; Resilience; Risk factor reduction; Stroke; Treatment

Mesh:

Year:  2019        PMID: 31327392      PMCID: PMC7001744          DOI: 10.1016/j.jalz.2019.06.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  123 in total

1.  Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein.

Authors:  F Zhang; C Eckman; S Younkin; K K Hsiao; C Iadecola
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

2.  Bilingualism delays age at onset of dementia, independent of education and immigration status.

Authors:  Suvarna Alladi; Thomas H Bak; Vasanta Duggirala; Bapiraju Surampudi; Mekala Shailaja; Anuj Kumar Shukla; Jaydip Ray Chaudhuri; Subhash Kaul
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

3.  Impaired behavioural flexibility related to white matter microgliosis in the TgAPP21 rat model of Alzheimer disease.

Authors:  Alexander Levit; Aaron M Regis; Andrew Gibson; Olivia H Hough; Shikhar Maheshwari; Yuksel Agca; Cansu Agca; Vladimir Hachinski; Brian L Allman; Shawn N Whitehead
Journal:  Brain Behav Immun       Date:  2019-02-15       Impact factor: 7.217

4.  Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.

Authors:  Sean M Nestor; Bratislav Mišić; Joel Ramirez; Jiali Zhao; Simon J Graham; Nicolaas P L G Verhoeff; Donald T Stuss; Mario Masellis; Sandra E Black
Journal:  Alzheimers Dement       Date:  2017-01-27       Impact factor: 21.566

5.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.

Authors:  C Iadecola; F Zhang; K Niwa; C Eckman; S K Turner; E Fischer; S Younkin; D R Borchelt; K K Hsiao; G A Carlson
Journal:  Nat Neurosci       Date:  1999-02       Impact factor: 24.884

Review 6.  Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review.

Authors:  Blossom C M Stephan; Ratika Birdi; Eugene Yee Hing Tang; Theodore D Cosco; Lorenzo M Donini; Silvan Licher; M Arfan Ikram; Mario Siervo; Louise Robinson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Concomitant vascular and neurodegenerative pathologies double the risk of dementia.

Authors:  Mahmoud Reza Azarpazhooh; Abolfazl Avan; Lauren E Cipriano; David G Munoz; Luciano A Sposato; Vladimir Hachinski
Journal:  Alzheimers Dement       Date:  2017-09-30       Impact factor: 21.566

8.  Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.

Authors:  Jorge Sepulcre; Michel J Grothe; Federico d'Oleire Uquillas; Laura Ortiz-Terán; Ibai Diez; Hyun-Sik Yang; Heidi I L Jacobs; Bernard J Hanseeuw; Quanzheng Li; Georges El-Fakhri; Reisa A Sperling; Keith A Johnson
Journal:  Nat Med       Date:  2018-10-29       Impact factor: 53.440

9.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

10.  Increased Uptake of AV-1451 in a Subacute Infarction Lesion.

Authors:  Soo Hyun Cho; Hanna Cho; Seongbeom Park; Young Hoon Ryu; Jae Yong Choi; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo; Hee Jin Kim
Journal:  Yonsei Med J       Date:  2018-06       Impact factor: 2.759

View more
  58 in total

Review 1.  Magnetic Resonance Imaging Studies of Neurodegenerative Disease: From Methods to Translational Research.

Authors:  Peiyu Huang; Minming Zhang
Journal:  Neurosci Bull       Date:  2022-06-30       Impact factor: 5.203

Review 2.  Molecular mechanisms of cognitive impairment associated with stroke.

Authors:  Mandeep Kaur; Saurabh Sharma
Journal:  Metab Brain Dis       Date:  2022-01-14       Impact factor: 3.584

Review 3.  Immune responses to stroke: mechanisms, modulation, and therapeutic potential.

Authors:  Costantino Iadecola; Marion S Buckwalter; Josef Anrather
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

4.  Prevalence and correlates of mild cognitive impairment among diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging results.

Authors:  Hector M González; Wassim Tarraf; Neil Schneiderman; Myriam Fornage; Priscilla M Vásquez; Donglin Zeng; Marston Youngblood; Linda C Gallo; Martha L Daviglus; Richard B Lipton; Robert Kaplan; Alberto R Ramos; Melissa Lamar; Sonia Thomas; Albert Chai; Charles DeCarli
Journal:  Alzheimers Dement       Date:  2019-11-18       Impact factor: 21.566

5.  Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol.

Authors:  Joanna M Wardlaw; Fergus Doubal; Rosalind Brown; Ellen Backhouse; Lisa Woodhouse; Philip Bath; Terence J Quinn; Thompson Robinson; Hugh S Markus; Richard McManus; John T O'Brien; David J Werring; Nikola Sprigg; Adrian Parry-Jones; Rhian M Touyz; Steven Williams; Yee-Haur Mah; Hedley Emsley
Journal:  Eur Stroke J       Date:  2020-10-11

6.  Sex differences in the association between major cardiovascular risk factors in midlife and dementia: a cohort study using data from the UK Biobank.

Authors:  Jessica Gong; Katie Harris; Sanne A E Peters; Mark Woodward
Journal:  BMC Med       Date:  2021-05-19       Impact factor: 11.150

7.  The APOE gene cluster responds to air pollution factors in mice with coordinated expression of genes that differs by age in humans.

Authors:  Amin Haghani; Max Thorwald; Todd E Morgan; Caleb E Finch
Journal:  Alzheimers Dement       Date:  2020-11-20       Impact factor: 21.566

8.  Non-coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in women.

Authors:  Elizabeth E Blue; Timothy A Thornton; Charles Kooperberg; Simin Liu; Jean Wactawski-Wende; JoAnn Manson; Lew Kuller; Kathleen Hayden; Alexander P Reiner
Journal:  Alzheimers Dement       Date:  2020-09-23       Impact factor: 21.566

Review 9.  Hypertension-induced cognitive impairment: from pathophysiology to public health.

Authors:  Zoltan Ungvari; Peter Toth; Stefano Tarantini; Calin I Prodan; Farzaneh Sorond; Bela Merkely; Anna Csiszar
Journal:  Nat Rev Nephrol       Date:  2021-06-14       Impact factor: 42.439

Review 10.  Contrasting Metabolic Insufficiency in Aging and Dementia.

Authors:  Dennis A Turner
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.